United States

Acasti Pharma Inc (ACST.O)

ACST.O on Consolidated Issue listed on NASDAQ Capital Market

21 Oct 2016
Change (% chg)

$-0.05 (-3.53%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Acasti posts qtrly loss per share of $0.29
Monday, 11 Jul 2016 05:30pm EDT 

Acasti Pharma Inc: Acasti announces first quarter results .Qtrly loss per share $0.29.  Full Article

Acasti Pharma says Jan D'Alvise named as CEO
Thursday, 12 May 2016 08:08am EDT 

Acasti Pharma Inc : Says Jan D'Alvise appointed as president and chief executive officer effective June 1, 2016 .Jan D'Alvise appointed president & CEO of Acasti Pharma.  Full Article

Acasti Pharma Inc says appointment of Roderick Carter, as Executive Chairman of the Board
Tuesday, 1 Mar 2016 08:00am EST 

Acasti Pharma Inc:Says appointment of Roderick Carter, as Executive Chairman of the Board.  Full Article

Acasti Pharma Inc announces departure of chief financial officer
Wednesday, 29 Apr 2015 06:35pm EDT 

Acasti Pharma Inc:Says departure of andré godin as chief financial officer effective immediately.  Full Article

BRIEF-Acasti Pharma Q2 loss per share $0.22

* if co does not raise additional funds, there exists uncertainty that casts substantial doubt about ability to continue as going concern